| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| GAL | GNAI1 | ENSCPOP00000003911 | ENSCPOP00000030063 | Galanin and GMAP prepropeptide. | Uncharacterized protein. | 0.540 |
| GAL | GNAI3 | ENSCPOP00000003911 | ENSCPOP00000010346 | Galanin and GMAP prepropeptide. | Guanine nucleotide-binding protein G(i) subunit alpha; Heterotrimeric guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Signaling by an activated GPCR promotes GDP release and GTP binding. The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal. Both GDP release and GTP hydrolysis are modul [...] | 0.540 |
| GAL | OPRD1 | ENSCPOP00000003911 | ENSCPOP00000028801 | Galanin and GMAP prepropeptide. | Opioid receptor delta 1; Belongs to the G-protein coupled receptor 1 family. | 0.678 |
| GAL | OPRK1 | ENSCPOP00000003911 | ENSCPOP00000005950 | Galanin and GMAP prepropeptide. | Kappa-type opioid receptor; G-protein coupled opioid receptor that functions as receptor for endogenous alpha-neoendorphins and dynorphins, but has low affinity for beta-endorphins. Also functions as receptor for various synthetic opioids and for the psychoactive diterpene salvinorin A. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by r [...] | 0.728 |
| GAL | OPRL1 | ENSCPOP00000003911 | ENSCPOP00000024516 | Galanin and GMAP prepropeptide. | Nociceptin receptor; G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide- binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociceptio [...] | 0.672 |
| GAL | OPRM1 | ENSCPOP00000003911 | ENSCPOP00000015591 | Galanin and GMAP prepropeptide. | Mu-type opioid receptor; Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone. Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP- bound G-protein alpha and the G-protein beta-gamma dimer activating downstream cellular effectors. The agonist- and cell ty [...] | 0.695 |
| GAL | PDYN | ENSCPOP00000003911 | ENSCPOP00000019436 | Galanin and GMAP prepropeptide. | Alpha-neoendorphin; Leu-enkephalins compete with and mimic the effects of opiate drugs. They play a role in a number of physiologic functions, including pain perception and responses to stress (By similarity). Leumorphin has a typical opiod activity and may have anti- apoptotic effect. | 0.759 |
| GAL | PENK | ENSCPOP00000003911 | ENSCPOP00000027030 | Galanin and GMAP prepropeptide. | Met-enkephalin-Arg-Gly-Leu; Met- and Leu-enkephalins compete with and mimic the effects of opiate drugs. They play a role in a number of physiologic functions, including pain perception and responses to stress. PENK(114-133) and PENK(238-259) increase glutamate release in the striatum. PENK(114-133) decreases GABA concentration in the striatum. | 0.738 |
| GAL | PNOC | ENSCPOP00000003911 | ENSCPOP00000026399 | Galanin and GMAP prepropeptide. | Prepronociceptin. | 0.742 |
| GAL | POMC | ENSCPOP00000003911 | ENSCPOP00000020054 | Galanin and GMAP prepropeptide. | Corticotropin-like intermediary peptide; ACTH stimulates the adrenal glands to release cortisol. Beta-endorphin and Met-enkephalin are endogenous opiates. [Melanocyte-stimulating hormone alpha]: Anorexigenic peptide. Increases the pigmentation of skin by increasing melanin production in melanocytes. [Beta-endorphin]: Endogenous orexigenic opiate. | 0.786 |
| GNAI1 | GAL | ENSCPOP00000030063 | ENSCPOP00000003911 | Uncharacterized protein. | Galanin and GMAP prepropeptide. | 0.540 |
| GNAI1 | GNAI3 | ENSCPOP00000030063 | ENSCPOP00000010346 | Uncharacterized protein. | Guanine nucleotide-binding protein G(i) subunit alpha; Heterotrimeric guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Signaling by an activated GPCR promotes GDP release and GTP binding. The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal. Both GDP release and GTP hydrolysis are modul [...] | 0.726 |
| GNAI1 | OPRD1 | ENSCPOP00000030063 | ENSCPOP00000028801 | Uncharacterized protein. | Opioid receptor delta 1; Belongs to the G-protein coupled receptor 1 family. | 0.923 |
| GNAI1 | OPRK1 | ENSCPOP00000030063 | ENSCPOP00000005950 | Uncharacterized protein. | Kappa-type opioid receptor; G-protein coupled opioid receptor that functions as receptor for endogenous alpha-neoendorphins and dynorphins, but has low affinity for beta-endorphins. Also functions as receptor for various synthetic opioids and for the psychoactive diterpene salvinorin A. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by r [...] | 0.784 |
| GNAI1 | OPRL1 | ENSCPOP00000030063 | ENSCPOP00000024516 | Uncharacterized protein. | Nociceptin receptor; G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide- binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociceptio [...] | 0.817 |
| GNAI1 | OPRM1 | ENSCPOP00000030063 | ENSCPOP00000015591 | Uncharacterized protein. | Mu-type opioid receptor; Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone. Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP- bound G-protein alpha and the G-protein beta-gamma dimer activating downstream cellular effectors. The agonist- and cell ty [...] | 0.923 |
| GNAI1 | PNOC | ENSCPOP00000030063 | ENSCPOP00000026399 | Uncharacterized protein. | Prepronociceptin. | 0.627 |
| GNAI1 | POMC | ENSCPOP00000030063 | ENSCPOP00000020054 | Uncharacterized protein. | Corticotropin-like intermediary peptide; ACTH stimulates the adrenal glands to release cortisol. Beta-endorphin and Met-enkephalin are endogenous opiates. [Melanocyte-stimulating hormone alpha]: Anorexigenic peptide. Increases the pigmentation of skin by increasing melanin production in melanocytes. [Beta-endorphin]: Endogenous orexigenic opiate. | 0.598 |
| GNAI3 | GAL | ENSCPOP00000010346 | ENSCPOP00000003911 | Guanine nucleotide-binding protein G(i) subunit alpha; Heterotrimeric guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Signaling by an activated GPCR promotes GDP release and GTP binding. The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal. Both GDP release and GTP hydrolysis are modul [...] | Galanin and GMAP prepropeptide. | 0.540 |
| GNAI3 | GNAI1 | ENSCPOP00000010346 | ENSCPOP00000030063 | Guanine nucleotide-binding protein G(i) subunit alpha; Heterotrimeric guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades. The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state. Signaling by an activated GPCR promotes GDP release and GTP binding. The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal. Both GDP release and GTP hydrolysis are modul [...] | Uncharacterized protein. | 0.726 |